Abiopharma

Clinical trial NCT02908906: enrollment: 413 → 234 participants.

Clinical trial NCT07519525 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-26 3. primary completion date: 2026-05-01 → 2026-05-26 4. enrollment: 8 → 7 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06411899 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-17 → 2026-05-14 3. primary completion date: 2025-06-17 → 2025-09-02

Clinical trial NCT04699838: primary completion date: 2026-03-01 → 2026-07-01.

Clinical trial NCT06561347 updates: 1. enrollment: 55 → 56 participants 2. collaborators added: BeOne Medicines 3. collaborators removed: BeiGene

Clinical trial NCT06411379 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-17 → 2026-05-20 3. primary completion date: 2025-06-17 → 2025-08-14

Clinical trial NCT07144111 updates: 1. completion date: 2026-09-09 → 2026-09-06 2. primary completion date: 2026-09-05 → 2026-09-04

Clinical trial NCT05670106 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-04-22

Clinical trial NCT00419380: enrollment: 40 → 41 participants.

Clinical trial NCT06949644 updates: 1. completion date: 2029-07-31 → 2029-08-31 2. primary completion date: 2029-02-28 → 2029-07-31